111 related articles for article (PubMed ID: 37863686)
21. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
22. Does Fragmentation of Care in Locally Advanced Rectal Cancer Increase Patient Mortality?
Freischlag K; Olivere L; Turner M; Adam M; Mantyh C; Migaly J
J Gastrointest Surg; 2021 May; 25(5):1287-1296. PubMed ID: 32754789
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis.
Uson Junior PLS; Carvalho L; Fernandes MLC; Botrus G; de Souza Martins R; da Silva EF; Dos Santos SSMB; Taniwaki L; Taranto P; Dutra ACP; de Oliveira Filho JB; Araujo SEA; Moura F
Sci Rep; 2022 Aug; 12(1):13592. PubMed ID: 35948602
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy is associated with improved survival in patients with left-sided pancreatic adenocarcinoma.
Ocuin LM; Hardacre JM; Ammori JB; Rothermel LD; Mohamed A; Selfridge JE; Bajor D; Winter JM
J Surg Oncol; 2020 Dec; 122(8):1595-1603. PubMed ID: 32844445
[TBL] [Abstract][Full Text] [Related]
25. The importance of multimodal therapy in the management of nonmetastatic adenosquamous carcinoma of the pancreas: Analysis of treatment sequence and strategy.
Hue JJ; Katayama E; Sugumar K; Winter JM; Ammori JB; Rothermel LD; Hardacre JM; Ocuin LM
Surgery; 2021 May; 169(5):1102-1109. PubMed ID: 33376004
[TBL] [Abstract][Full Text] [Related]
26. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
[TBL] [Abstract][Full Text] [Related]
27. Quality of care in accredited and nonaccredited ambulatory surgical centers.
Menachemi N; Chukmaitov A; Brown LS; Saunders C; Brooks RG
Jt Comm J Qual Patient Saf; 2008 Sep; 34(9):546-51. PubMed ID: 18792659
[TBL] [Abstract][Full Text] [Related]
28. Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.
Passeri MJ; Baker EH; Siddiqui IA; Templin MA; Martinie JB; Vrochides D; Iannitti DA
Curr Oncol; 2019 Jun; 26(3):e346-e356. PubMed ID: 31285679
[TBL] [Abstract][Full Text] [Related]
29. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
[TBL] [Abstract][Full Text] [Related]
31. Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma.
Zhang B; Lee GC; Qadan M; Fong ZV; Mino-Kenudson M; Desphande V; Malleo G; Maggino L; Marchegiani G; Salvia R; Scarpa A; Luchini C; De Gregorio L; Ferrone CR; Warshaw AL; Lillemoe KD; Bassi C; Castillo CF
Ann Surg; 2021 Aug; 274(2):e134-e142. PubMed ID: 31851002
[TBL] [Abstract][Full Text] [Related]
32. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival.
Altman AM; Wirth K; Marmor S; Lou E; Chang K; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
Ann Surg Oncol; 2019 Nov; 26(12):4108-4116. PubMed ID: 31313044
[TBL] [Abstract][Full Text] [Related]
33. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage.
Vega EA; Kutlu OC; Salehi O; Alarcon SV; Abudalou M; Kozyreva O; Krishnan S; Lee D; Freeman R; Conrad C
Surg Oncol; 2022 Mar; 40():101694. PubMed ID: 34973593
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.
Sell NM; Lee GC; Fernández-Del Castillo C; Ferrone CR; Warshaw AL; Hong TS; Blaszkowsky LS; Lillemoe KD; Qadan M
Pancreas; 2020 Aug; 49(7):897-903. PubMed ID: 32658070
[TBL] [Abstract][Full Text] [Related]
36. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.
Barnes CA; Chavez MI; Tsai S; Aldakkak M; George B; Ritch PS; Dua K; Clarke CN; Tolat P; Hagen C; Hall WA; Erickson BA; Evans DB; Christians KK
Surgery; 2019 Sep; 166(3):277-285. PubMed ID: 31272811
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
[TBL] [Abstract][Full Text] [Related]
39. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.
Miller ME; Bleicher RJ; Kaufman CS; Kurtzman SH; Chang C; Wang CH; Pollitt KA; Connolly J; Winchester DP; Yao KA
Ann Surg Oncol; 2019 May; 26(5):1202-1211. PubMed ID: 30684159
[TBL] [Abstract][Full Text] [Related]
40. Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.
Swords DS; Zhang C; Presson AP; Firpo MA; Mulvihill SJ; Scaife CL
Surgery; 2018 Apr; 163(4):753-760. PubMed ID: 29248179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
